- acute myeloid leukemia (AML)
- aplastic anemia
- chronic lymphocytic leukemia (CLL)
- chronic myelomonocytic leukaemia (CMML)
- graft versus host disease (GVHD)
- myelodysplastic syndromes (MDS)
- myeloproliferative neoplasms (MPN)
- paroxysmal nocturnal hemoglobinuria (PNH)
- pure red cell aplasia (PRCA)
Dr. Niyongere joined the School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center as an Assistant Professor in 2018. Her clinical focus is in acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms and bone marrow failure syndromes.
Dr. Niyongere’s primary research interests are in finding new therapeutic targets by understanding oncogenic signaling pathways involved in AML and MDS as well as studying the role of the tumor microenvironment in the development of chemoresistance in leukemia. Dr. Niyongere also serves as an attending physician on the inpatient leukemia service training fellows, internal medicine residents and medical students.
- accepting new patients